ARI0002H
not tagged
['mmsm', 'car-t', 'multiple myeloma']
#eha2022 #presidentialsymposium efficacy and safety of ari0002h, an academic bcma-directed car-t cell therapy with fractionated initial therapy and booster dose in patients with relapsed/refractory multiple myeloma #hematology #mmsm 
Lymphoma Unit @Hospital_FJD & @UICOquironsalud. Board member @sehh_es & @SIOGorg. Councilor @EHA_Hematology Executive Board. Chairman SWG “Aging and Hematology”